GH Prakiraan wutah bathi resik saben saham ing taun iki Guardant Corp

By recruiting leading bioinformaticians and molecular biologists, Guardant Health, Inc. (GH) has expanded its R&D potential. The annual net income per share trend reflects the current market consensus, while -1.90 marks a new level. Looking ahead, the company aims for expansion driven by FDA-approved liquid biopsy tests and aggressive management investment in clinical trials to achieve profitability.

GH Wutah bathi saben saham ing taun lumaku Guardant360 (04.07.2022 - 13.11.2026)

Rincian metrik komprehensif lan analitis Guardant Health, Inc. (GH)

- nilai saham lan prakiraan konsensus rega:

Rega bursa Guardant Health Inc|GH - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar Guardant Corp|GH - Nilai Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Saham Guardant Health|GH - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku guardanthealth.com|GH - Total Aset Perusahaan

- indikator beban utang lan likuiditas:

Rasio Utang marang Modal Guardant Health, Inc.|GH - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal guardanthealth.com|GH - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Guardant Corp|GH - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Guardant Health|Rasio likuiditas darurat guardanthealth.com

- data bathi lan kelipatan valuasi:

GH - Bathi resik|Proyeksi bathi mangsa ngarep Guardant Health, Inc.|GH - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Guardant Corp|GH - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Guardant Corp|GH - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Guardant Health|GH - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan guardanthealth.com|GH - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Guardant Health, Inc.

Pambiji fundamental:Guardant Health, Inc.

For Guardant Health, Inc. (GH), outsourcing sequencer production and cloud computing directly impacts the annual growth rate of net earnings per share by optimizing capital expenditures. This indicator captures the percentage shift in earnings per share relative to the previous year, isolating fundamental business growth from market volatility, which allows investors to assess the real efficiency of the operating model and the asset's resilience.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku Caris Life Sciences Inc (CAI)|Wutah bathi saben saham ing taun lumaku Veracyte Corp|Celcuity Therapeutics (CELC) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku GRAL|Prakiraan wutah bathi resik saben saham ing taun iki myriad.com|Wutah bathi saben saham ing taun lumaku Castle Biosciences, Inc. CSTL|Prakiraan wutah bathi resik saben saham ing taun iki Burning Rock Biotech Limited (BNR)|VolitionRx Ltd - Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Biodesix Corporation (BDSX)|PRPO (Precipio, Inc.) - Wutah bathi resik saben saham ing taun iki|Check-Cap (CHEK) - Wutah bathi ing taun lumaku|MYNZ (Mainz Biomed) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku OncoCyte Corp